Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Plasma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00133367
What this trial is testing

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Who this might be right for
Multiple MyelomaNon-Hodgkin's LymphomaHodgkin's Disease+2 more
Massachusetts General Hospital 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Not applicableStudy completedNCT05763563
What this trial is testing

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Who this might be right for
LymphomaLeukemiaMyeloma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT04205409
What this trial is testing

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+15 more
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Not applicableStudy completedNCT04039100
What this trial is testing

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

Who this might be right for
Multiple MyelomaLymphomaBone Marrow Transplantation+3 more
Rigshospitalet, Denmark 43
Testing effectiveness (Phase 2)Study completedNCT00353860
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

Who this might be right for
ImmunosuppressionLeukemia
National Heart, Lung, and Blood Institute (NHLBI) 70
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Post-approval studies (Phase 4)Study completedNCT00361140
What this trial is testing

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Lymphocytic+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)UnknownNCT01016990
What this trial is testing

Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Auxilio Mutuo Cancer Center 52
Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT00676806
What this trial is testing

A Phase II Study of Umbilical Cord Blood Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+1 more
Tufts Medical Center 7
Large-scale testing (Phase 3)Study completedNCT03595800
What this trial is testing

Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen

Who this might be right for
Acute LeukemiaNon Hodgkin LymphomaMultiple Myeloma
Institut Paoli-Calmettes 9
Testing effectiveness (Phase 2)Ended earlyNCT01658904
What this trial is testing

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Who this might be right for
Multiple MyelomaLeukemia, Plasma Cell
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Looking for participantsNCT04728893
What this trial is testing

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Who this might be right for
Hematologic MalignanciesWaldenstroms MacroglobulinaemiaNon-Hodgkins Lymphoma+1 more
Merck Sharp & Dohme LLC 490
Large-scale testing (Phase 3)Looking for participantsNCT07202052
What this trial is testing

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Who this might be right for
MyelomaNon-Hodgkin's LymphomaLeukemia
Monash University 900
Not applicableEnded earlyNCT00005786
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more
National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)UnknownNCT00003924
What this trial is testing

Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Study Association 360
Early research (Phase 1)Study completedNCT00562224
What this trial is testing

Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients

Who this might be right for
Neoplasms by SiteLymphoma, Non-hodgkinHodgkin Disease+2 more
Pharmacyclics LLC. 36
Not applicableStudy completedNCT00003196
What this trial is testing

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
Fred Hutchinson Cancer Center 63
Next Page